About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Category Archives: Finance
FDA Funding – When the Audience Changes, the Message Must Change
On March 11, Dr. Margaret Hamburg presented testimony before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies regarding funding for the FDA. Her remarks did a capable job of outlining what the FDA does and … Continue reading
Posted in FDA Image, Finance, Legislation
1 Comment
Bloomberg on Earnings
Here is the latest from Bloomberg Amgen – Lilly
Posted in Finance
Comments Off on Bloomberg on Earnings
For Investors
Here is a new addition to the Eye on FDA YouTube channel going under the Investment Vids playlist from Morningstar on Biotech stocks to watch. Morningstar associate director of equity research Debbie Wang offers her take on possible takeout targets:
Posted in Finance
Comments Off on For Investors